Erratum: Primary prevention of cardiovascular disease and type 2 diabetes in patients at metabolic risk: An endocrine society clinical practice guideline (The Journal of Clinical Endocrinology and Metabolism (2019) 104:9 (3939-3985) DOI: 10.1210/jc.2019-01338)

J. L. Rosenzweig, G. L. Bakris, L. F. Berglund, M. F. Hivert, E. S. Horton, R. R. Kalyani, M. H. Murad, B. L. Vergès

Research output: Contribution to journal › Comment/debate › peer-review

Fingerprint

Dive into the research topics of 'Erratum: Primary prevention of cardiovascular disease and type 2 diabetes in patients at metabolic risk: An endocrine society clinical practice guideline (The Journal of Clinical Endocrinology and Metabolism (2019) 104:9 (3939-3985) DOI: 10.1210/jc.2019-01338)'. Together they form a unique fingerprint.

Medicine & Life Sciences

Chemical Compounds